• FirefoxUpgrade to the new Firefox »
  •  Dow Down 0.05% Nasdaq Up 0.07%

    More On HQL

    Quotes

    Charts

    News & Info

    Company

    • Profile
    • Key Statistics
    • SEC Filings
    • Competitors
    • Industry
    • Components

    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates

    Ownership

    Financials

    Tekla Life Sciences Investors (HQL)

    -NYSE
    27.33 Down 0.17(0.62%) 11:01AM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:27.50
    Open:27.73
    Bid:27.22 x 100
    Ask:27.35 x 100
    1y Target Est:N/A
    Beta:1.18
    Next Earnings Date:N/A
    Day's Range:27.21 - 27.74
    52wk Range:19.24 - 27.74
    Volume:23,343
    Avg Vol (3m):101,892
    Market Cap:N/A
    P/E (ttm):5.82
    EPS (ttm):4.70
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est () :N/A
    Quarterly EPS Est () :N/A
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback